Midline Catheter and Its Impact on Central Lines Removal in ICU — MIDREA  

Vascular Access Device Clinical Trial

Official title: Midline Catheter and Its Impact on Central Lines Removal in ICU

Status Terminated

Clinical Trial Summary

The study will evaluate 2 strategies to remove central venous catheter (CVC): in one part, the insertion of a midline catheter and in the other part, the conventional insertion of peripheral venous catheter (PVC)

Clinical Trial Description

Patients will be randomised when the last indication for CVC has disappeared, which means parenteral nutrition or vasopressors administration.

They will be randomised either in the midline group or in the PVC group.

• In the midline group, a midline catheter will try to be inserted before the 48th hour after last indication for CVC disappeared.

• In the PVC group: a PVC will try to be inserted before the 48th hour after last indication for CVC disappeared.

If successful, CVC will then be removed. If not, a PVC will try to be inserted daily till success or worthlessness of a venous line or death.

The presence of a CVC will be assessed at the 96th hour after disappearance of last CVC indication. ;

Related Conditions & MeSH terms

• Vascular Access Device

• NCT number: NCT03675711
• Study type: Interventional
• Source: Centre Hospitalier Departemental Vendee
• Status: Terminated
• Phase: N/A
• Start date: November 2, 2018
• Completion date: January 13, 2023